Add Yahoo as a preferred source to see more of our stories on Google. The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo ...
Sanofi SA (NASDAQ: SNY) has been found to have violated the U.K.'s pharmaceutical marketing code after a senior executive made misleading claims in an October 2024 interview, prompting a complaint ...
Pre-exposure prophylaxis clinical trials of a 3-dose regimen of Verorab® followed by a booster dose at 1 year in adults and children achieved an adequate immune response.1 Of those who had a booster ...
In a ruling published Wednesday, the UK's Advertising Standards Authority (ASA) upheld a complaint against Sanofi UK ruling that a paid promotion of the company's pharmacy-only Phenergan Night Time ...
Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in London, U.K. The acquisition brings an early-stage combination vaccine ...
Sanofi agreed to buy UK biotech Vicebio Ltd. for as much as $1.6 billion, gaining experimental vaccines and a technology to streamline their development. The French drugmaker will pay $1.15 billion ...
The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes Feb 2 (Reuters) - Sanofi has breached the UK pharma code of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results